Document Detail

Food labeling: health claims; antioxidant vitamins C and E and the risk of atherosclerosis, coronary heart disease, certain cancers, and cataracts--FDA. Interim final rule.
MedLine Citation:
PMID:  10180284     Owner:  NLM     Status:  MEDLINE    
The Food and Drug Administration (FDA) is issuing an interim final rule to prohibit the use on foods of a claim relating to the relationship between antioxidant vitamins C and E and the risk in adults of atherosclerosis, coronary heart disease, certain cancers, and cataracts. This rule is in response to a notification of a health claim submitted under section 303 of the FDA Modernization Act of 1997 (FDAMA). FDA has reviewed statements that the petitioner submitted in that notification, and, in conformity with the requirements of FDAMA, the agency is prohibiting the claim because the statements submitted as the basis of the claim are not "authoritative statements" of a scientific body, as required by FDAMA; therefore, section 303 of FDAMA does not authorize use of this claim. As provided for in section 301 of FDAMA, this rule is effective immediately upon publication.
Related Documents :
18983884 - Fda's food ingredient approval process: safety assurance based on scientific assessment.
19824584 - Changing winds: practice implications of acetaminophen regulations.
11382584 - Implantable middle ear hearing devices: food and drug administration review process.
23465574 - Monitoring trace elements in antarctic penguin chicks from south shetland islands, anta...
15563444 - Dietary intake and the risk of coronary heart disease among the coconut-consuming minan...
11729074 - Biology and ecology of higher diptera from freshwater wetlands.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Federal register     Volume:  63     ISSN:  0097-6326     ISO Abbreviation:  Fed Regist     Publication Date:  1998 Jun 
Date Detail:
Created Date:  1998-07-22     Completed Date:  1998-07-22     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7808722     Medline TA:  Fed Regist     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  34084-91     Citation Subset:  H    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Arteriosclerosis / prevention & control
Ascorbic Acid / therapeutic use*
Cataract / prevention & control
Coronary Disease / prevention & control
Drug Approval / legislation & jurisprudence*
Food Labeling / legislation & jurisprudence*
Neoplasms / prevention & control
Risk Factors
United States
United States Food and Drug Administration
Vitamin E / therapeutic use*
Reg. No./Substance:
1406-18-4/Vitamin E; 50-81-7/Ascorbic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Medicare program; payment for teleconsultations in rural health professional shortage areas--HCFA. P...
Next Document:  Food labeling: health claims; antioxidant vitamin A and beta-carotene and the risk in adults of athe...